Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2000
03/28/2000US6043098 Method for the preparation of free radical pharmaceuticals, diagnostics and devices using selenium conjugates
03/28/2000US6043094 Therapeutic liposome composition and method
03/28/2000US6043082 Two genetic constructs encoding chimeric proteins, each with ligand binding domain to complex with the other protein; one protein also with domain which induces biological process, the other having intracelluar targeting domain; gene therapy
03/28/2000US6043026 Mixture of an estrogen receptor modulator and a growth hormone secretagogue
03/28/2000US6042847 Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application
03/28/2000US6042845 Anti fungal treatment of nails
03/28/2000US6042839 Containing water soluble carboxylated gum and clay crosslinked with metal ions; for cosmetic and/or pharmaceutical products
03/28/2000US6042830 Viral agent associated with mystery swine disease
03/28/2000US6042829 Biotherapy of cancer by targeting TP-3/P80
03/28/2000US6042822 Mixture of alpha-interferon-conjugate positional isomers comprises an alpha-interferon covalently conjugated to a non-antigenic alkyl terminated polyalkylene oxide at a histidine residue on alpha interferon
03/28/2000US6042820 Biodegradable copolymer containing α-hydroxy acid and α-amino acid units
03/28/2000US6042811 Containing a particulate drug, a diol/diacid condensate as a dispersing aid and a propellant
03/28/2000CA2180658C Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor
03/28/2000CA2173815C Use of a hydrofluorocarbon in an emulsion; composition and emulsion containing such a compound
03/28/2000CA2063862C Topical preparation containing a suspension of solid lipid particles
03/23/2000WO2000015825A1 Condensed plasmid-liposome complex for transfection
03/23/2000WO2000015766A1 Treatment of oncologic tumors with an injectable formulation of a golgi apparatus disturbing agent
03/23/2000WO2000015663A1 MIP-1α ISOFORM LD78β AND USES THEREOF
03/23/2000WO2000015272A1 Polymer immobilized living cells and applications thereof
03/23/2000WO2000015263A1 Expandible microparticle intracellular delivery system
03/23/2000WO2000015262A1 Dry powder active agent pulmonary delivery
03/23/2000WO2000015261A1 Compositions comprising sympathomimetic amine salts unsuitable for illegal use
03/23/2000WO2000015258A1 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
03/23/2000WO2000015245A2 Stable liquid formulations of botulinum toxin
03/23/2000WO2000015233A1 Compositions for the treatment of male erectile dysfunction
03/23/2000WO2000015224A1 Protein formulations
03/23/2000WO2000015203A2 Use of methoxymorpholino doxorubicin for the treatment of a liver tumor
03/23/2000WO2000015202A2 Topical application products
03/23/2000WO2000015198A1 Orally administered controlled drug delivery system providing temporal and spatial control
03/23/2000WO2000015196A1 Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
03/23/2000WO2000015195A1 Quick release pharmaceutical compositions of drug substances
03/23/2000WO2000015194A1 Calcium phosphate delivery vehicle and adjuvant
03/23/2000WO2000015193A1 Mousse composition
03/23/2000WO2000015192A1 Methods and materials related to bioadhesive contraceptive gels
03/23/2000WO2000015036A1 Topical dermal antimicrobial compositions
03/23/2000WO2000007603A3 End modified thermal responsive hydrogels
03/23/2000WO1999067359A3 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore
03/23/2000WO1999066901A3 Transdermal therapeutic system containing hormones and crystallization inhibitors
03/23/2000WO1999065493A9 Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects
03/23/2000WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
03/23/2000DE19843027A1 Transdermal therapeutic system used for administration of sex hormones contains neohesperidin dihydrochalcone to inhibit crystallization of active agent
03/23/2000DE19842914A1 Testsystem zur Charakterisierung der Verträglichkeit von biologisch aktiven Substanzen und Polyvinylpyrrolidon Test system for the characterization of the compatibility of biologically active substances and polyvinylpyrrolidone
03/23/2000DE19842753A1 Multiple-unit retard oral dosage formulation having controlled release independent of agitation and food effect, containing particles of combination of drug and hydroxypropyl cellulose
03/23/2000CA2344441A1 Expandible microparticle intracellular delivery system
03/23/2000CA2344316A1 Treatment of oncologic tumors with an injectable formulation of a golgi apparatus disturbing agent
03/23/2000CA2343920A1 Aerosolizable particles resistant to hygroscopic growth
03/23/2000CA2343760A1 Orally administered controlled drug delivery system providing temporal and spatial control
03/23/2000CA2343268A1 Protein formulations
03/23/2000CA2343220A1 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis
03/23/2000CA2342292A1 Condensed plasmid-liposome complex for transfection
03/23/2000CA2342243A1 Stable liquid formulations of botulinum toxin
03/23/2000CA2342207A1 Calcium phosphate delivery vehicle and adjuvant
03/23/2000CA2341972A1 Polymer immobilized living cells and applications thereof
03/23/2000CA2339354A1 Compositions comprising sympathomimetic amine salts unsuitable for illegal use
03/22/2000EP0987917A1 Method of cell data transmission, cell, communication system and corresponding network terminal unit
03/22/2000EP0987549A2 Test composition for determining the compatibility of biologically active materials with polyvinylpyrrolidone
03/22/2000EP0987275A2 Molecules that home to a selected organ or tissue in vivo and methods of identifying same
03/22/2000EP0987029A1 Use of a catonic polymer for the preparation of a complex with nucleic acid and related compositions
03/22/2000EP0987028A1 Pharmaceutical compositions comprising Hedgehog-Proteins and their use
03/22/2000EP0987019A1 Topical antibiotic composition for rapid wound healing
03/22/2000EP0986602A1 Process for preparing porous polyolefin particles
03/22/2000EP0986599A2 Process for the preparation of copolyesters
03/22/2000EP0986596A1 Biodegradable polyester urethanes, method for the production and use thereof
03/22/2000EP0986568A1 Novel class of nucleic acid cationic transfecting agents
03/22/2000EP0986404A2 Gene therapy delivery system for targeting to endothelia
03/22/2000EP0986403A1 Polar drug or prodrug compositions with extended shelf-life storage and a method of making thereof
03/22/2000EP0986402A2 Reversible geling co-polymer and method of making
03/22/2000EP0986392A1 Method of treating chronic progressive vascular scarring diseases
03/22/2000EP0986373A1 Drug targeting system, method of its preparation and its use
03/22/2000EP0986309A1 Uses of oil bodies
03/22/2000EP0866814B1 Copolymers of olefinically unsaturated monocarboxylic acids, olefinically unsaturated dicarboxylic acids or their anhydrides or mixtures of such carboxylic acids or anhydrides and their use as thickeners and dispersants
03/22/2000EP0860170B1 Tablets based on isotope-labeled urea
03/22/2000EP0782442A4 A delivery system for antimethanogenic agents
03/22/2000EP0772776B1 Superparamagnetic particles, process for their production and their use
03/22/2000EP0705085B1 Molecular transdermal transport system
03/22/2000EP0671912B1 Injectable taxane derivative based compositions
03/22/2000EP0506774B2 Smoking substitute
03/22/2000CN1248177A Coated particles, method of making and using
03/22/2000CN1248165A Nimesulide gel system for topical use
03/22/2000CN1248163A Pharmaceutical preparation comprising lyophilized lipsomes encapsulating active principle which is highly insoluble in water, and the process for preparing the said preparation
03/22/2000CN1248162A Topical pharmaceutical composition comprising cholinergic agent or calcium channel blocker
03/22/2000CN1050514C Antiallergic composition for ophthalmic or nasal use
03/21/2000US6040336 Treating bacterially induced meningitis
03/21/2000US6040330 Pharmaceutical formulations of taxanes
03/21/2000US6040297 A therapeutic agents treating tumors and retroviral infections including hiv infections
03/21/2000US6040295 Prolong the bioavailability of a nucleic acid molecule by injecting a solutions comprising a nucleic acid molecule and an amphiphilic compound select from polyvinyl pyrrolidone, polyvinyl alcohol, polyethylene glycol or propylene glycol
03/21/2000US6040197 Method for the preparation of free radical pharmaceuticals, diagnostics and devices using selenium conjugates
03/21/2000US6040167 Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems
03/21/2000US6040136 Phagemid expression vector having a transcription regulatory sequence linked to gene encoding a fusion protein of a polypeptide and a bacteriophage coat protein; for library of proteins expressed in low quantity on particle surface
03/21/2000US6039981 Itraconazole, phosphoric acid with carriers as fungicides
03/21/2000US6039977 Water and polyvinyl alcohol with drug to form hydrogel for drug delivery
03/21/2000US6039976 Enteric film coating compositions, method of coating therewith, and coated forms
03/21/2000US6039974 Drugs of multilayer tablets
03/21/2000US6039970 Nasal administering bioactive drugs with hyaluronic acid derivatives, dissolving in dimethyl sulfoxide, adding to mineral oil, ethyl acetate, filtration
03/21/2000US6039967 Intravesical drug delivery system
03/21/2000US6039963 Ceramide compounds, process for their preparation and use
03/21/2000US6039945 Administering purified prothrombinase factor to humans
03/21/2000US6039943 Removal of blood from vitreous humor of blood
03/21/2000US6039940 Inherently antimicrobial quaternary amine hydrogel wound dressings
03/21/2000US6039813 Fructose-based granulated product and a process for the production thereof
1 ... 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 ... 1712